% | $
Quotes you view appear here for quick access.

Chiquita Brands International Inc. Message Board

macrocosmonaut 12 posts  |  Last Activity: Jun 26, 2015 12:29 PM Member since: Aug 30, 2006
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • macrocosmonaut macrocosmonaut Apr 13, 2015 1:07 PM Flag

    Stock has lost 90 Percent since last year high as expexted.

    The same #$%$ has burned millions of Dollars of Investors again.

    Sentiment: Sell

  • macrocosmonaut macrocosmonaut Apr 13, 2015 1:08 PM Flag

    The stock is heavily overvalued at current stock price levels. The stock is valued more than 40-times of its equity and its burning cash.

    Obviously OHRP is the same company like Genaera - the same products and the same people.

    The trial results has in the endpoint data no significance with sight on the high P-values. Further I has no trust to the trial results, after Squalamine treatment in the trials of Genaera at 2007 has shown no significant effects or only marginal effects in the treatment of back of the eye diseases.

    So OHRP is even able to go bankrupt like Genaera a few years ago. The trials are very expensive and a statistical significant effect remains questionable.

    Additional risk are existing by the fact that many shareholdes has presumably bought this stock by margin.

    Even from technical point of view this stock is showing profit takting signals. Current measured bear move is indication a significant drop of stock price in future.

    Stock is able to become a penny stock within the next few years. Especially if the US Dollar will devaluate in significant manner.

    Price target 0.50 USD per share. If the trials fails the company will go ...

    Sentiment: Sell

  • macrocosmonaut by macrocosmonaut Apr 13, 2015 1:09 PM Flag

    No significant value driver and a management overpaid and propably corrupt.


    See my estimate of last year when this stock was at around 20 USD per share...;_ylt=AicyUTKrGos658AS8x66u1neAohG;_ylu=X3oDMTB1cDZkbG52BHBvcwM4BHNlYwNNZWRpYU1zZ0JvYXJkc1hIUlVsdA--;_ylg=X3oDMTBhYWM1a2sxBGxhbmcDZW4tVVM-;_ylv=3?&bn=60b3e151-bedc-33b3-9979-5a583abbe1f1&tid=1407283964848-6719bcbf-06d1-4987-9ac3-8b78ca6cc218

    Sentiment: Sell

  • Chart patterns are improoving - the stock is moving up in a weak global market. This is bullish...

    For the first time of more than 6 months the stock has closed on weekly and monthly basis above 0.50 USD.

    The stock is increasing its PPS today on high volume. Block trade are reflecting institutional buying at HTM.

    Volume is supporting a bullish outbreak scenario in future. Normally volume increases in front of strong market movements.

    At Canada there are only 4000 shares at 0.64 CAD$ at the ask.

    It seems to be that some people now more than the others.

    Near term price target 0.64 USD afterwards 0.80 US$.

    Midterm PT - 1.08 USD and above the 1.08 USD the stock will run up to the 2-3 USD range.

    Longterm PT is minimum 12 USD.

    IMO. Do your own due dilligence.


    Sentiment: Strong Buy

  • macrocosmonaut macrocosmonaut May 29, 2015 4:19 PM Flag

    I think the stock must override the 1.08 USD high of last year. If this happens the stock can easily run up to 5 USD and afterwards will start a multiyear longterm upmove to 10-20 USD probably more...

    Sentiment: Strong Buy

  • macrocosmonaut macrocosmonaut Jun 12, 2015 4:28 PM Flag

    Proove the prediction of me in future.

    If you have no clue about technical patterns, try to improove your knowledge.

    The stock has completed now on weekly basis a small cup handle formation within the big cup handle formation.

    Chart patterns are improoving and 50/100 MDA bullish cross over and upcoming 50/200 MDA bullish cross over are indicating that this stock is under accumulation and able to override its longterm buy trigger at 1.08 USD in future.

    Increasing positive divergence development is further indicating that the upcoming upward impuls will be stronger, the longer the stock remains under 1.08 USD.

    IMO - do your own due dilligence.


    Sentiment: Strong Buy

  • Next will be a 50/200 MDA bullish cross over next week.

    Above 0.60 USD the upward dynamic will rapidly increasing.

    The stock remains undervalued.

    Do your own due dilligence.


    Sentiment: Strong Buy

  • ...propably this stock is starting to develop a three white soldiere candle pattern within the next 3 weeks. In such a case the stock is able to climb in a longterm view several dollars.

    Increasing stock prices and increasing volume are indication improoving upward dynamic.


    Sentiment: Strong Buy

  • The stock has developed a longterm buy signal.

    A 50/200 MDA bullish cross over is indicating a longterm substantial upmove of the stock in future.

    Do your own due dilligence.

    Sentiment: Strong Buy

  • Reply to

    HTM - 50/200 MDA bullish crossover....

    by macrocosmonaut Jun 19, 2015 5:45 PM
    macrocosmonaut macrocosmonaut Jun 22, 2015 5:39 PM Flag

    MDA = Moving daily average - this is correct.

    A 50/200 MDA bullish cross over is a longterm buysignal. When 50 MDA is crossing the 200 MDA this is generating a strategic buy signal = bullish.

    Note that 200 MDA will even follow normally with a backlog of time to the upside.

    A small cup handle formation even has been completed within a big cup handle formation.

    Trend is up. Above 1.08 US on close basis, the longterm perspective of this stock will improve further. In such a case this stock is able to rise multidollars in future per share.


    Do your own due dilligence.

    Sentiment: Strong Buy

  • macrocosmonaut by macrocosmonaut Jun 24, 2015 6:56 PM Flag

    I am downgrading NVAX from strong buy - see my recommendation of the year 2009 and 2010 - to sell.

    After the stock has reached the 10 USD price level - the risks of massive draw down are very high.

    Investors should take a look at the insider selling which starts at 5 USD in massive manner.

    So with a market cap of 3 billion USD this stock is now overvalued.


    Sentiment: Sell

  • macrocosmonaut by macrocosmonaut Jun 26, 2015 12:29 PM Flag

    Oral application of Cannabidiol is one possibility of drug delivery. Transdermal delivery seems to be the betthe better choise.

    So Nass Valley Gateway has published a letter of intent to buy SR Hadden - a pharmaceutical start up with a technology of transdermal Cannabidiol application.

    I think it is worth to think about to invest in such undervalued companies like Nass Valley Gateway.

    If the deal with Nass Valley Gateway and RS Hadden - GWPH has a new competitor in the Cannabidiol treatment space.